Answers are grounded in this paper and cite their sources.
Objective To discuss the immune reaction in the animals inoculated with the recombinant adenovirus. Method The structural gene (vp3 + vp1) of HAV-L8 was amplified from its RNA by RT-PCR and was cloned into And shuttle plasmid (pXCX_2 Not I). A recombinant replication-defective adenovirus was rescued in 293 packaging cells via homologous recombination in vivo of both plasmid pXCX_2-CMV-HAV and pJM17 containing Ad5 genome with deletions of E1 region. Results A series of methods such as RT-PCR, immunofluorescence and western blot were employed to identify the generated recombinant adenovirus (rAdHAV). The titer of stocks of rAdHAV was up to 1 * 10~(9.0) TCID_(50)/mL. After rAdHAV was delivered to Kunming mice by oral administration, anti-HAV IgG was tested in the mice. Conclusions A recombinant replication-defective adenovirus will become an efficient vector system to develop an oral virus vaccine.
No takes yet. Share an insight, caveat, or question.
Thelander et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: